Groupers Based on Infusion and or Injection

This Editorial Guide is used for Education Purposes Only. It is used in the Authoring Courses and Certifications. It is based on the January 2026 Editorial Guide.

Pharmaceutical dose form grouper concepts specifying "infusion and/or injection" are modeled using General Concept Inclusions (GCIs).

• For example,

  • 1208958005 |Conventional release solution for infusion and/or injection (dose form)|

  • 1236769008 |Gas for conventional release dispersion for infusion and/or injection (dose form)|

  • 1237269000 |Concentrate for conventional release solution for infusion and/or injection (dose form)|

The following are out of scope for the international release but can be added to national extensions, concepts that specify:

• "infusion or injection"

• "infusion and injection"

Clinical drugs with infusion and/or injection

Clinical drugs modeled using pharmaceutical dose form groupers for “infusion and/or injection” are in scope for the International Release.

For example,

1252729004 |Product containing precisely ofloxacin 2 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug)| is modeled with |Has manufactured dose form (attribute)| of |Conventional release solution for infusion and/or injection (dose form)|.

In cases where corresponding clinical drugs for both injection and infusion exist, the grouper for “infusion and/or injection” should be created. In other words, when creating a new clinical drug for infusion and an existing injection concept exists with the same substance and strength, then the grouper "for infusion and/or injection" should be created.

For example,

Provide Feedback